Medifast

MED · NYSE

$12.06+$0.03 (+0.25%)TodayMarket closed ·
Prev close $12.03

Latest news

  • Press releaseBusiness Wire

    Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026

  • Press releasePRNewswire

    Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update

  • Press releaseBusiness Wire

    Medifast® Announces the Launch of the Medifast Metabolic Health Institute™

  • News

    11 Consumer Staples Stocks Moving In Monday's After-Market Session

  • News

    Medifast Q2 Adj. EPS $(0.28) Beats $(0.65) Estimate, Sales $76.384M Beat $72.700M Estimate

  • Press releaseBusiness Wire

    Medifast Announces Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

  • Press releaseBusiness Wire

    Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System

  • Press releaseBusiness Wire

    Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer

  • Press releaseBusiness Wire

    Medifast Announces First Quarter 2026 Financial Results

  • News

    Earnings Scheduled For May 4, 2026

  • News

    12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

  • Press releaseBusiness Wire

    Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026

  • Press releasePRNewswire

    SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)

  • Press releaseBusiness Wire

    Medifast Announces Cooperation Agreement with Steamboat Capital

  • Press releaseBusiness Wire

    Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

  • News

    Medifast Q4 2025 Earnings Call Transcript

  • Press releaseBusiness Wire

    Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

  • News

    Earnings Scheduled For February 17, 2026

  • News

    What to Expect from Medifast's Earnings

  • Press releaseBusiness Wire

    Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

  • Press releasePRNewswire

    The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings

  • Press releaseBusiness Wire

    People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®

  • Press releaseBusiness Wire

    OPTAVIA® Premieres Second Docuseries Episode "Health by Design: Spain" Exploring Metabolic Health and Longevity

  • Press releaseBusiness Wire

    Medifast Announces Planned Leadership Transition

  • Press releaseBusiness Wire

    OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

  • Press releaseBusiness Wire

    Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

  • Press releaseBusiness Wire

    Medifast Announces Third Quarter 2025 Financial Results

  • Press releaseBusiness Wire

    Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

  • Press releaseBusiness Wire

    Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

  • Press releaseBusiness Wire

    Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

  • Press releaseBusiness Wire

    Medifast Announces Second Quarter 2025 Financial Results

  • News

    Uncovering Potential: Medifast's Earnings Preview

  • NewsErica Kollmann

    Trump Calls For More Tariffs, Federal Reserve Minutes On Deck: What's Driving Markets Wednesday?

  • Press releaseBusiness Wire

    Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

  • Press releaseBusiness Wire

    Medifast Announces Third Quarter 2024 Financial Results

  • Press releaseBusiness Wire

    Medifast Announces Second Quarter 2024 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.